DEF 14A Filing

Company

AIM ImmunoTech Inc.

Filed

July 30, 2008

Period of Report

September 17, 2008

Accession Number

0001144204-08-042864

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →